InVivoMAb anti-mouse BTLA (CD272)
BE0304
ApplicationsFlow Cytometry, Other Application
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse BTLA (CD272)
- Delivery Days Customer7
- ApplicationsFlow Cytometry, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID6F7
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostMouse
- IsotypeIgG1
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Zelinskyy G, Myers L, Dietze KK, et al. Virus-specific CD8+ T cells upregulate programmed death-1 expression during acute friend retrovirus infection but are highly cytotoxic and control virus replication. J Immunol. 2011,187(7):3730-7. doi: 10.4049/jimmunol.1101612Read this paper
- Truong W, Hancock WW, Plester JC, et al. BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice. J Leukoc Biol. 2009,86(1):41-51. doi: 10.1189/jlb.1107753Read this paper
- Steinberg MW, Turovskaya O, Shaikh RB, et al. A crucial role for HVEM and BTLA in preventing intestinal inflammation. J Exp Med. 2008,205(6):1463-76. doi: 10.1084/jem.20071160Read this paper
- Truong W, Plester JC, Hancock WW, et al. Combined coinhibitory and costimulatory modulation with anti-BTLA and CTLA4Ig facilitates tolerance in murine islet allografts. Am J Transplant. 2007,7(12):2663-74.Read this paper
- Hurchla MA, Sedy JR, Gavrieli M, et al. B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cells. J Immunol. 2005,174(6):3377-85.Read this paper
